# Kremezin Study Against Renal Disease Progression in Korea

> **NCT00860431** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 578 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** AST-120

## Key facts

- **NCT ID:** NCT00860431
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 578 (ESTIMATED)
- **Last updated:** 2014-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00860431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00860431, "Kremezin Study Against Renal Disease Progression in Korea". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT00860431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*